Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05296889 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Post-Market Clinical Follow-Up Study on the Safety and Performance of Ennovate® Cervical

Study acronym: CERISE
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 1 year 1 month later Jun 2026 → Aug 2027
See other at-risk trials from Aesculap AG

Record History

  1. Primary completion pushed from Jun 2026 to Aug 2027 Completion pushed from Jul 2026 to Sep 2028 · Site details revised at 1 of 4 sitesv8 Show 2 more changesShow less
    • Completion pushed from Jul 2026 to Sep 2028
    • Site details revised at 1 of 4 sites
  2. Primary completion date: Dec 2025 to Jun 2026 Completion date: Dec 2026 to Jul 2026v7 Show 1 more changeShow less
    • Completion date: Dec 2026 to Jul 2026
  3. Primary completion date: Feb 2025 to Dec 2025 Completion date: Dec 2025 to Dec 2026v6 Show 1 more changeShow less
    • Completion date: Dec 2025 to Dec 2026
  4. Primary completion date: Dec 2024 to Feb 2025v5
  5. Completion date: Dec 2024 to Dec 2025v4
Show 2 earlier versionsHide 2 earlier versions
  1. Primary completion date: Jul 2023 to Dec 2024 Study sites: 1 to 4v3 Show 1 more changeShow less
    • Study sites: 1 to 4
  2. Re-verified, no change to tracked fieldsv2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Aesculap AG
32 trials monitored
See 6 trials at risk
Multicenter Post market clinical follow-up Study on the Safety and Performance of Ennovate® Cervical - Prospective, pure data collection of all Ennovate Cervical patients in Total Indications
Trial Details
NCT Number NCT05296889
Lead Sponsor Aesculap AG
Collaborators: Raylytic GmbH
Conditions Spine Fracture, Degenerative Disc Disease, Spinal Instability, Spinal Tumor, Degenerative Myelopathy
Enrollment 200 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov